Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease Transcript

Verdict

Headline takes no side. We score EQ +0.50 — strongly bullish.

Headline says

No call

No rating or direction in the headline

Expected · EQ

+0.50strongly bullish

−1 bearish0bullish +1

More positive than 64% of ticker scores this week

Actual